{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=sex+therapy&page=6",
    "query": {
      "intervention": "sex therapy",
      "page": 6
    },
    "page_size": 10
  },
  "pagination": {
    "page": 6,
    "page_size": 10,
    "total_count": 947,
    "total_pages": 95,
    "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=sex+therapy&page=7&page_size=10",
    "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=sex+therapy&page=5&page_size=10"
  },
  "source": "remote",
  "last_synced_at": "2026-10-07T16:30:15.899Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT02654366",
      "title": "Community Supported Risk Reduction for Syringe Exchange Participants",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Substance Use Disorders",
        "Risk Reduction"
      ],
      "interventions": [
        {
          "name": "Risk Reduction Group",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "Johns Hopkins University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "70 Years",
        "sex": "ALL",
        "summary": "18 Years to 70 Years"
      },
      "enrollment_count": 87,
      "start_date": "2016-05",
      "completion_date": "2019-08-31",
      "has_results": false,
      "last_update_posted_date": "2020-03-20",
      "last_synced_at": "2026-10-07T16:30:15.899Z",
      "location_count": 1,
      "location_summary": "Baltimore, Maryland",
      "locations": [
        {
          "city": "Baltimore",
          "state": "Maryland"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02654366"
    },
    {
      "nct_id": "NCT00797654",
      "title": "HIV Prevention and Trauma Treatment in Men Who Have Sex With Men and Who Have a History of Sexual Abuse",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Risk Reduction"
      ],
      "interventions": [
        {
          "name": "Information-motivation-behavior skills and cognitive processing therapy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Pre and Post HIV-Test Counseling",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "Fenway Community Health",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "MALE",
        "summary": "18 Years and older · Male only"
      },
      "enrollment_count": 46,
      "start_date": "2008-08",
      "completion_date": "2011-05",
      "has_results": false,
      "last_update_posted_date": "2016-08-09",
      "last_synced_at": "2026-10-07T16:30:15.899Z",
      "location_count": 2,
      "location_summary": "Boston, Massachusetts",
      "locations": [
        {
          "city": "Boston",
          "state": "Massachusetts"
        },
        {
          "city": "Boston",
          "state": "Massachusetts"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00797654"
    },
    {
      "nct_id": "NCT03578783",
      "title": "PSD502 in Subjects With Premature Ejaculation",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Premature Ejaculation"
      ],
      "interventions": [
        {
          "name": "Placebo",
          "type": "DRUG"
        },
        {
          "name": "PSD502",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "Plethora Solutions Ltd",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "MALE",
        "summary": "18 Years and older · Male only"
      },
      "enrollment_count": 121,
      "start_date": "2018-12-26",
      "completion_date": "2021-12-01",
      "has_results": false,
      "last_update_posted_date": "2022-07-05",
      "last_synced_at": "2026-10-07T16:30:15.899Z",
      "location_count": 21,
      "location_summary": "Birmingham, Alabama • Mobile, Alabama • Sherman Oaks, California + 18 more",
      "locations": [
        {
          "city": "Birmingham",
          "state": "Alabama"
        },
        {
          "city": "Mobile",
          "state": "Alabama"
        },
        {
          "city": "Sherman Oaks",
          "state": "California"
        },
        {
          "city": "Boynton Beach",
          "state": "Florida"
        },
        {
          "city": "Miami",
          "state": "Florida"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03578783"
    },
    {
      "nct_id": "NCT03981822",
      "title": "A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Condylomata Acuminata",
        "Papillomavirus Infections",
        "Skin Diseases, Viral",
        "Skin Diseases, Infectious",
        "Skin Diseases",
        "Sexually Transmitted Diseases, Viral",
        "Sexually Transmitted Diseases",
        "Warts"
      ],
      "interventions": [
        {
          "name": "VP-102 and applicator",
          "type": "COMBINATION_PRODUCT"
        },
        {
          "name": "Placebo",
          "type": "COMBINATION_PRODUCT"
        }
      ],
      "intervention_types": [
        "COMBINATION_PRODUCT"
      ],
      "sponsor": "Verrica Pharmaceuticals Inc.",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 105,
      "start_date": "2019-06-25",
      "completion_date": "2020-07-08",
      "has_results": true,
      "last_update_posted_date": "2024-11-27",
      "last_synced_at": "2026-10-07T16:30:15.899Z",
      "location_count": 4,
      "location_summary": "Plainfield, Indiana • Baton Rouge, Louisiana • Clarkston, Michigan + 1 more",
      "locations": [
        {
          "city": "Plainfield",
          "state": "Indiana"
        },
        {
          "city": "Baton Rouge",
          "state": "Louisiana"
        },
        {
          "city": "Clarkston",
          "state": "Michigan"
        },
        {
          "city": "Tulsa",
          "state": "Oklahoma"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03981822"
    },
    {
      "nct_id": "NCT02897804",
      "title": "Engineering an Online STI Prevention Program",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Sexual Behavior",
        "Alcohol Consumption",
        "Sexually Transmitted Diseases"
      ],
      "interventions": [
        {
          "name": "Knowledge alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Self-efficacy alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Perceived benefits alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Perceived benefits and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Injunctive norms",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Injunctive norms and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Injunctive norms and perceived benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Injunctive norms, perceived benefits, and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms and perceived benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms,perceived benefits,self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive and injunctive norms",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive norms, injunctive norms,self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive and injunctive norms, benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Descriptive and injunctive norms, benefits,efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies alone",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies and Perceived Benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, perceived benefits, self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies and injunctive norms",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, injunctive norms, and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, injunctive norms, benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, injunctive norms, benefits, efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies and descriptive norms",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descriptive norms, and self-efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descriptive norms, and benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies,descriptive norms, benefits, efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descriptive and injunctive norms",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, descr& injun norms, efficacy",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies, desc & injun norms, benefits",
          "type": "BEHAVIORAL"
        },
        {
          "name": "Expectancies,desc & injun norms,benefits,efficacy",
          "type": "BEHAVIORAL"
        }
      ],
      "intervention_types": [
        "BEHAVIORAL"
      ],
      "sponsor": "Penn State University",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "30 Years",
        "sex": "ALL",
        "summary": "18 Years to 30 Years"
      },
      "enrollment_count": 3997,
      "start_date": "2016-08",
      "completion_date": "2017-06",
      "has_results": false,
      "last_update_posted_date": "2019-01-09",
      "last_synced_at": "2026-10-07T16:30:15.899Z",
      "location_count": 4,
      "location_summary": "Fresno, California • Carbondale, Illinois • Greensboro, North Carolina + 1 more",
      "locations": [
        {
          "city": "Fresno",
          "state": "California"
        },
        {
          "city": "Carbondale",
          "state": "Illinois"
        },
        {
          "city": "Greensboro",
          "state": "North Carolina"
        },
        {
          "city": "Fargo",
          "state": "North Dakota"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02897804"
    },
    {
      "nct_id": "NCT05616130",
      "title": "Pathological Myeloid Activation After Sepsis and Trauma",
      "overall_status": "RECRUITING",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Trauma Injury",
        "Sepsis",
        "Immunosuppression",
        "Chronic Critical Illness"
      ],
      "interventions": [
        {
          "name": "Data Collection",
          "type": "OTHER"
        },
        {
          "name": "Bone marrow collection and blood collection",
          "type": "PROCEDURE"
        },
        {
          "name": "Serial interviews to complete surveys and questionnaires",
          "type": "OTHER"
        },
        {
          "name": "Telephone follow up call",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "OTHER",
        "PROCEDURE"
      ],
      "sponsor": "University of Florida",
      "sponsor_class": "OTHER",
      "healthy_volunteers": null,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "100 Years",
        "sex": "ALL",
        "summary": "18 Years to 100 Years"
      },
      "enrollment_count": 255,
      "start_date": "2022-09-01",
      "completion_date": "2028-09-30",
      "has_results": false,
      "last_update_posted_date": "2025-12-26",
      "last_synced_at": "2026-10-07T16:30:15.899Z",
      "location_count": 1,
      "location_summary": "Gainesville, Florida",
      "locations": [
        {
          "city": "Gainesville",
          "state": "Florida"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05616130"
    },
    {
      "nct_id": "NCT04823130",
      "title": "Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE4"
      ],
      "conditions": [
        "Dermatitis Atopic"
      ],
      "interventions": [
        {
          "name": "Dupilumab (SAR231893)",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "Sanofi",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 54,
      "start_date": "2021-04-22",
      "completion_date": "2022-08-30",
      "has_results": true,
      "last_update_posted_date": "2025-09-16",
      "last_synced_at": "2026-10-07T16:30:15.899Z",
      "location_count": 2,
      "location_summary": "Miami, Florida • East Windsor, New Jersey",
      "locations": [
        {
          "city": "Miami",
          "state": "Florida"
        },
        {
          "city": "East Windsor",
          "state": "New Jersey"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT04823130"
    },
    {
      "nct_id": "NCT00931528",
      "title": "Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ],
      "conditions": [
        "Prostate Cancer",
        "Sexual Dysfunction"
      ],
      "interventions": [
        {
          "name": "Tadalafil",
          "type": "DRUG"
        },
        {
          "name": "Placebo",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "DRUG",
        "OTHER"
      ],
      "sponsor": "Radiation Therapy Oncology Group",
      "sponsor_class": "NETWORK",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "120 Years",
        "sex": "MALE",
        "summary": "18 Years to 120 Years · Male only"
      },
      "enrollment_count": 242,
      "start_date": "2009-11",
      "completion_date": "2014-11",
      "has_results": true,
      "last_update_posted_date": "2018-02-14",
      "last_synced_at": "2026-10-07T16:30:15.899Z",
      "location_count": 183,
      "location_summary": "Birmingham, Alabama • Mobile, Alabama • Peoria, Arizona + 151 more",
      "locations": [
        {
          "city": "Birmingham",
          "state": "Alabama"
        },
        {
          "city": "Mobile",
          "state": "Alabama"
        },
        {
          "city": "Peoria",
          "state": "Arizona"
        },
        {
          "city": "Scottsdale",
          "state": "Arizona"
        },
        {
          "city": "Scottsdale",
          "state": "Arizona"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00931528"
    },
    {
      "nct_id": "NCT00865566",
      "title": "Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men",
      "overall_status": "TERMINATED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "HIV Infections"
      ],
      "interventions": [
        {
          "name": "DNA plasmid vaccine",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Recombinant adenoviral serotype 5 (rAD5) vector vaccine",
          "type": "BIOLOGICAL"
        },
        {
          "name": "DNA vaccine placebo",
          "type": "BIOLOGICAL"
        },
        {
          "name": "HIV-1 recombinant adenovirus vaccine placebo",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL"
      ],
      "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)",
      "sponsor_class": "NIH",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "50 Years",
        "sex": "MALE",
        "summary": "18 Years to 50 Years · Male only"
      },
      "enrollment_count": 2504,
      "start_date": "2009-05",
      "completion_date": "2017-10-06",
      "has_results": true,
      "last_update_posted_date": "2021-10-15",
      "last_synced_at": "2026-10-07T16:30:15.899Z",
      "location_count": 22,
      "location_summary": "Birmingham, Alabama • Los Angeles, California • San Francisco, California + 15 more",
      "locations": [
        {
          "city": "Birmingham",
          "state": "Alabama"
        },
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "Los Angeles",
          "state": "California"
        },
        {
          "city": "San Francisco",
          "state": "California"
        },
        {
          "city": "Aurora",
          "state": "Colorado"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00865566"
    },
    {
      "nct_id": "NCT05722301",
      "title": "Does Testosterone Therapy Improve Patient-Reported Outcomes in Age-Related Testosterone Deficient Patients Undergoing Total Hip Replacement: A Randomized-Controlled Trial",
      "overall_status": "WITHDRAWN",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ],
      "conditions": [
        "Arthroplasty, Replacement, Hip"
      ],
      "interventions": [
        {
          "name": "Testosterone Therapy",
          "type": "DRUG"
        },
        {
          "name": "No Testosterone Therapy",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "DRUG",
        "OTHER"
      ],
      "sponsor": "American Hip Institute",
      "sponsor_class": "OTHER",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "50 Years",
        "maximum_age": null,
        "sex": "MALE",
        "summary": "50 Years and older · Male only"
      },
      "enrollment_count": 0,
      "start_date": "2019-11-01",
      "completion_date": "2021-11-01",
      "has_results": false,
      "last_update_posted_date": "2023-02-10",
      "last_synced_at": "2026-10-07T16:30:15.899Z",
      "location_count": 1,
      "location_summary": "Des Plaines, Illinois",
      "locations": [
        {
          "city": "Des Plaines",
          "state": "Illinois"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05722301"
    }
  ]
}